Now showing items 1-1 of 1
Optimisation of the Lister strain of vaccinia virus for use as an anticancer immunotherapeutic agent
(Queen Mary University of London, 20/01/2015)
The premise of this project was to engineer a novel viral platform with the capacity to enhance antitumour immunity. To this effect, the N1L gene was disrupted in a Lister strain vaccinia viral backbone that had previously ...